Eledon Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2013 to Q3 2024.
  • Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.78M, a 2.83% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $8.25M, a 30.8% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.55M, a 19.7% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.15M, a 3.15% increase from 2021.
  • Eledon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.9M, a 149% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $8.25M $1.78M +$49K +2.83% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $8.2M $3.06M +$1.34M +78.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $6.86M $1.69M +$313K +22.7% Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-08-19
Q4 2023 $6.55M $1.71M +$236K +16% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-08-19
Q3 2023 $6.31M $1.73M -$451K -20.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $6.76M $1.72M -$588K -25.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-19
Q1 2023 $7.35M $1.38M -$805K -36.8% Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-08-19
Q4 2022 $8.15M $1.47M -$579K -28.2% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-08-19
Q3 2022 $8.73M $2.19M +$142K +6.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $8.59M $2.31M +$274K +13.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $8.32M $2.19M +$412K +23.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.9M $2.05M +$394K +23.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $7.51M $2.04M +$1.17M +133% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $6.35M $2.03M +$1.84M +932% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $4.51M $1.77M +$1.34M +306% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.17M $1.66M +$1.42M +583% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $1.76M $878K +$651K +287% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.1M $197K -$430K -68.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.53M $437K +$226K +107% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $1.31M $243K -$498K -67.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $1.81M $227K -$10K -4.22% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $1.82M $627K +$223K +55.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.59M $211K +$50K +31.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.54M $741K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 $237K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $404K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $161K +$55K +51.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 -$745K $106K -$916K -89.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $171K -$2.49M -$3.35M -390% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $3.52M $646K -$158K -19.7% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $3.68M $992K +$386K +63.7% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $3.29M $1.02M +$388K +61.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $2.9M $857K +$268K +45.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-03
Q3 2015 $2.63M $804K -$375K -31.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $3.01M $606K +$356K +142% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $2.65M $634K +$544K +604% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $2.11M $589K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 $1.18M +$1.13M +2409% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $250K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $90K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q3 2013 $47K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.